238 related articles for article (PubMed ID: 6214228)
21. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
Infection; 1986; 14(6):261-7. PubMed ID: 3546144
[TBL] [Abstract][Full Text] [Related]
22. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
Düzova A; Kutluk T; Kanra G; Büyükpamukçu M; Akyüz C; Seçmeer G; Ceyhan M
Turk J Pediatr; 2001; 43(2):105-9. PubMed ID: 11432485
[TBL] [Abstract][Full Text] [Related]
23. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
J Clin Oncol; 1983 Oct; 1(10):597-603. PubMed ID: 6366126
[TBL] [Abstract][Full Text] [Related]
24. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
Martino P; Venditti M; Petti MC; Mandelli F; Serra P
Infection; 1985; 13(3):125-9. PubMed ID: 3928495
[TBL] [Abstract][Full Text] [Related]
25. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
Gaya H
Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
[TBL] [Abstract][Full Text] [Related]
26. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Cometta A; Zinner S; de Bock R; Calandra T; Gaya H; Klastersky J; Langenaeken J; Paesmans M; Viscoli C; Glauser MP
Antimicrob Agents Chemother; 1995 Feb; 39(2):445-52. PubMed ID: 7726513
[TBL] [Abstract][Full Text] [Related]
27. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Rizal AM; Nordiah AJ; Jamal R
Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
[TBL] [Abstract][Full Text] [Related]
28. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
Gasparini G; Benedetti M; Fassio T; Canobbio L; Figoli F; Galligioni E; Talamini R; Toffoli G; Tumolo S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):113-20. PubMed ID: 3549581
[TBL] [Abstract][Full Text] [Related]
29. Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Finley RS; Fortner CL; deJongh CA; Wade JC; Newman KA; Caplan E; Britten J; Wiernik PH; Schimpff SC
Antimicrob Agents Chemother; 1982 Aug; 22(2):193-7. PubMed ID: 6765414
[TBL] [Abstract][Full Text] [Related]
30. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
31. [Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study].
Raffi F; Feve B; Tiab M; Brisseau JM; Reynaud AE; Grolleau JY
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):548-51. PubMed ID: 2385453
[TBL] [Abstract][Full Text] [Related]
32. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
33. Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure.
Miranda-Novales MG; Belmont-Martinez L; Villasis-Keever MA; Penagos-Paniagua M; Bernaldez-Rios R; Solorzano-Santos F
Arch Med Res; 1998; 29(4):331-5. PubMed ID: 9887552
[TBL] [Abstract][Full Text] [Related]
34. Empiric therapy of febrile granulocytopenic patients.
Hopefl AW
Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
[TBL] [Abstract][Full Text] [Related]
35. [Sulbenicillin and amikacin for febrile patients with cancer--with special reference to granulocytopenia].
Sampi K; Honda T; Hattori M
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2377-81. PubMed ID: 6639099
[TBL] [Abstract][Full Text] [Related]
36. [Piperacillin and amikacin in the treatment of infections in neoplasm patients with granulocytopenia].
Giaccone G; Bagatella M; Donadio M; Bonardi GM; Calciati A
Clin Ter; 1989 Aug 15-31; 130(3-4):191-5. PubMed ID: 2529094
[TBL] [Abstract][Full Text] [Related]
37. Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients.
Klastersky J; Debusscher L; Weerts-Ruhl D; Prevost JM
Cancer Treat Rep; 1977 Nov; 61(8):1433-9. PubMed ID: 922748
[No Abstract] [Full Text] [Related]
38. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
[TBL] [Abstract][Full Text] [Related]
39. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
40. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
